NHS Logo

Screening and Risk Reduction Strategies for Breast Cancer (Record no. 102487)

MARC details
000 -LEADER
fixed length control field 03944nam a22004815i 4500
001 - CONTROL NUMBER
control field 978-981-19-7630-8
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729135206.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 230301s2023 si | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9789811976308
-- 978-981-19-7630-8
072 #7 - SUBJECT CATEGORY CODE
Subject category code MMPH
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED080000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MKSH
Source thema
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source thema
245 10 - TITLE STATEMENT
Title Screening and Risk Reduction Strategies for Breast Cancer
Subtitle : Imaging Modality and Risk-Reduction Approaches /
250 ## - EDITION
Edition statement 1st ed. 2023.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Singapore :
Name of producer, publisher, distributor, manufacturer Springer Nature Singapore :
-- Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice 2023.
300 ## - PHYSICAL DESCRIPTION
Physical description XII, 189 p. 42 illus., 31 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - CONTENTS
Contents 1. Introduction of the whole issue -- 2. Breast cancer epidemiology: incidence, risks and subtype -- 3. Personalized genetic breast cancer risk estimation with polygenic risk scores -- 4. Mathematical model forassessing breast cancer risk -- 5. Cost-effectiveness Analysis of multigene testing -- 6. Hereditary breast cancer: Its biology, subtype and clinical phenotype -- 7. Surgical risk reduction of breast cancer -- 8. Medical risk reduction of breast cancer -- 9. Screening for breast cancer with mammography -- 10. Breast cancer screening: Weighing the benefits and harms -- 11. Breast cancer screening according to individual risk -- 12. MRI: Detection of noninvasive diseases -- 13. Significance of MRI for women having dense breasts -- 14. Ultrasound: screening of breast cancer -- 15. Detection of breast cancer by PET -- 16. Radiowave mammography -- 17. Photoacoustic imaging of breast cancer.
520 ## - ABSTRACT
Abstract This book provides readers with the most up-to-date practical information on breast cancer screening. Since breast cancers are highly heterogeneous, time to clinical onset from the initial carcinogenesis differs diversely between cancers. Pathological germline variants and driver mutations cause a high lifetime risk of breast cancer. The lifetime risks are various according to what genes are pathologically dysfunctional. Integrated omics and imaging technologies have established varying tumour characteristics. Thus, this book suggests that a more individualised scheme is required to improve breast cancer screening. A key aim is to demonstrate how multiple diagnostic imaging modalities such as mammography, ultrasonography, MRI, PET and dbPET improve breast cancer screening accuracy. Mammography screening alone may have a limited impact on breast cancer risk prediction. These issues are crucial to discuss. Clinical experts recommend that new modalities be incorporated for women with dense breasts, like ultrasonography, dynamic mammography, MRI and maybe breast-dedicated PET. Topics on these modalities are going to be summarized in this book. An in-depth review of these modalities is summarised in this book. In addition, new diagnostic modalities, including risk assessment tools, multi-cancer early detection tests using liquid biopsy, the role of protein biomarkers in breast cancer risk screening, challenges, and hopes for future advances, are also covered in this book.
650 #0 - SUBJECT HEADINGS
Subject term Medical radiology.
650 #0 - SUBJECT HEADINGS
Subject term Oncology.
9 (RLIN) 13364
650 #0 - SUBJECT HEADINGS
Subject term Surgery.
650 #0 - SUBJECT HEADINGS
Subject term Medicine.
650 14 - SUBJECT HEADINGS
Subject term Radiation Oncology.
650 24 - SUBJECT HEADINGS
Subject term Surgery.
650 24 - SUBJECT HEADINGS
Subject term Clinical Medicine.
700 1# - ADDED PERSONAL NAME
Added personal author Toi, Masakazu.
Relator term editor.
710 2# - ADDED CORPORATE NAME
Added corporate author SpringerLink (Online service)
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
245 ## - TITLE STATEMENT
Medium [E-Book]
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
912 ## -
-- ZDB-2-SME
912 ## -
-- ZDB-2-SXM
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Online 02/05/2024 Springer Medicine_2023   02/05/2024 https://go.openathens.net/redirector/nhs?url=https://doi.org/10.1007/978-981-19-7630-8 02/05/2024 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions